Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome

Vinaya Vasudevan, Robert Moldwin, Vinaya Vasudevan, Robert Moldwin

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating, chronic condition characterized by chronic pelvic pain, urinary urgency, and frequency and is well-known to be associated with a decrease in work productivity, emotional changes, sleep, sexual dysfunction, and mobility. Many metrics of quality of life (QoL) in this patient population have been developed; however, a unified, standardized approach to QoL in these patients has not been determined. The effects of IC/BPS and co-morbid conditions on QoL are described using current validated metrics. Next, data regarding successful treatment of IC/BPS in terms of QoL improvement are reviewed. While QoL is the single most important clinical measure of success in the treatment of patients suffering from IC/BPS, addressing QoL in this patient population remains a significant challenge, as its effects on QoL are highly variable and unable to be differentiated from the effects of comorbid conditions on QoL, including depression, poor sleep, and inability to work. Future studies will need to address treatment efficacy on the basis of IC/BPS specific QoL metrics, and multi-modal assessment and therapy to address comorbid disease will also play an important role in the future to ensure comprehensive management of these patients.

Keywords: Chronic pelvic pain; Interstitial cystitis; Interstitial cystitis symptom index (ICSI); King's health questionnaire; O'Leary-Sant questionnaire; Painful bladder syndrome; Quality of life.

References

    1. Barofsky I. Can quality or quality of life be defined? Qual Life Res. 2012;21:625–631.
    1. Felce D., Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16:51–74.
    1. WHOQOL . World Health Organization; 1997. Measuring quality of life. Programme on mental health: division of mental health and prevention of substance abuse; pp. 1–10.
    1. Michael Y.L., Kawachi I., Stampfer M.J., Colditz G.A., Curhan G.C. Quality of life amonth women with interstitial cystitis. J Urol. 2000;164:423–427.
    1. Held P.J., Hanno P.M., Wein A.J. Interstitial cystitis. Springer-Verlag; New York: 1990. Epidemiology of interstitial cystitis: 2; p. 29.
    1. Goin J.E., Olaleye D., Peters K.M., Steinert B., Habicht K., Wynant G. Psychometric analysis of the University of Wisconsin Interstitial Cystitis Scale: implications for use in randomized clinical trials. J Urol. 1998;159:1085–1090.
    1. Oleary M.P., Sant G.R., Fowler F.J., Whitmore K.E., Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49:58–63.
    1. Lubeck D.P., Whitmore K., Sant G.R., Alvarez-Horine S., Lai C. Psychometric validation of the O'Leary-Sant interstitial cystitis symptom index in a clinical trial of PentosanPolysulfate sodium. Urology. 2001;57:62–66.
    1. Ware J.E. SF-36 health survey update. Spine. 2000:3130–3139.
    1. Parsons C.L., Dell J., Stanford E.J., Bullen M., Kahn B.S., Waxell T. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60:573–578.
    1. Nickel J.C., Shoskes D., Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol. 2009;182:155–160.
    1. Bogart L.M., Suttorp M.J., Elliott M.N., Quentin Clemens J., Berry S.H. Validation of a quality-of-life scale for women with bladder pain syndrome/interstitial cystitis. Qual Life Res. 2012;21:1665–1670.
    1. Wagenlehner F.M.E., van Till J.W., Magri V., Perletti G., Houbiers J.G., Weidner W. National Institutes of health chronic prostatitis symptom index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013;63:953–959.
    1. Hebbar S., Pandey H., Chawla A. Understanding King's Health Questinonnaire (KHQ) in assessment of female urinary incontinence. Int J Res Med Sci. 2015;3:531–538.
    1. Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17:E141–E147.
    1. Quaghebeur J., Wyndaele J.J. Prevalence of lower urinary tract symptoms and level of quality of life in men and women with chronic pelvic pain. Scand J Urol. 2014;49:242–249.
    1. Romão A.P., Gorayeb R., Romão G.S., Poli-Neto O.B., dos Reis F.J., Rosa-e-Silva J.C. High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain. Int J Clin Pract. 2009;63:707–711.
    1. Rothrock N.E., Lutgendorf S.K., Kreder J.K. Coping strategies in paitents with interstitial cystitis: relationships with quality of life and depression. J Urol. 2003;169:233–236.
    1. Tripp D.A., Nickel J.C., Fitzgerald M.P., Mayer R., Stechyson N., Hsieh A. Sexual functioning, catastrophizing, depression, and pain as predictors of quality of life in women with interstitial cystitis/painful bladder syndrome. J Urol. 2009;730:987–992.
    1. Burthick C.W. Interstitial cystitis and chronic pelvic pain: new insights in neuropathology, diagnosis, and treatment. Clin Obstet Gynecol. 2003;46:811–823.
    1. Propert K.J., Mayer R., Nickel J.C., Payne C.K., Peters K.M., Teal V. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus calmette-guerin or placebo. J Urol. 2007;179:552–555.
    1. Tincello D., Walker A.C.H. Interstitial cystitis in the UK: results of a questionnaire of members of the interstitial cystitis support group. Eur J OB ReprodBiol. 2005;118:91–95.
    1. Koziol J.A., Clark D.C., Gittes R.F., Tan E.M. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149:465–469.
    1. Nickel J.C., Payne C.K., Forrest J., Lowell Parsons C., Wan G.J., Xiao X. The relationship among symptoms, sleep disturbances, and quality of life in patients with interstitial cystitis. J Urol. 2009;181:2555–2561.
    1. Beckett M.K., Elliot M.N., Clemens J.Q., Ewing B., Berry S.H. Consequences of interstitial cystitis/bladder pain symptoms on women's work participation and income: results from National Household Sample. J Urol. 2014;19:83–88.
    1. Pinto R., Lopes T., Frias B., Silva A., Silva J.A., Silva C.M. Trigonal injection of botulinum toxin a in patients with refractory bladder pain syndrome/intersitital cystitis. EAU. 2010;58:360–365.
    1. Perez-Marrero R., Emerson L.E., Feltis J.T. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140:36–39.
    1. Sant G.R., LaRock D.R. Standard intravesical therapies for interstitial cystitis. Urol Clin N Am. 1994;21:73–83.
    1. Rössberger J., Fall M., Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side-effects and treatment outcome. Scand J Urol Nephrol. 2005;39:73–77.
    1. Apostolidis A., Dasgupta P., Fowler C.J. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol. 2006;49:644–650.
    1. Payne C.K., Mosbaugh P.G., Forrest J.B., Evans R.J., Whitmore K.E., Antoci J.P. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol. 2005;173:1590–1594.
    1. Peeker R., Haghsheno M.A., Holmäng S., Fall M. Intravesical Bacillus calmette-guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol. 2000;164:1912–1916.
    1. Mayer R., Propert K.J., Peters K.M., Payne C.K., Zhang Y., Burks D. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol. 2005;173:1186–1191.
    1. Steinhoff G. The efficacy of chondroitin sulfate in treating interstitial cystitis. Eur Urol Suppl. 2003;2:14–16.
    1. Istek A., Ugurlucan F.G., Yasa C., Gokyildiz S., Yalcin O. Randomized trial of long-term effects of percutaneous tibial nerve stimulation on chronic pelvic pain. Arch Gynecol Obstet. 2014;290:291–298.
    1. Noru T., Fode M., Nordling J. Ileal conduit without cystectomy may be an appropriate option in the treatment of intractable bladder pain syndrome/interstitial cystitis. Scand J Urol. 2014;48:210–215.
    1. Dunn M., Ramsden P.D., Roberts J.B.M., Smith J.C., Smith P.J.B. Interstitial cystitis, treated by prolonged bladder distension. BJUI. 1977;49:641–645.
    1. Badenoch A.W. Chronic interstitial cystitis. BJUI. 1971;43:718–721.
    1. McCahy P.J., Styles R.A. Prolonged bladder distension: experience in the treatment of detrusor overactivity and interstitial cystitis. Eur Urol. 1995;28:325–327.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner